C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 99 filers reported holding C4 THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BALYASNY ASSET MANAGEMENT L.P. | 11,686 | $32,137 | 0.00% |
External links
This page lists C4 THERAPEUTICS INC's shareholders in Q2 2023. To view C4 THERAPEUTICS INC's shareholder history, click here.